Skip to main content
EJNMMI Research
Fig. 4 | EJNMMI Research

Fig. 4

From: Multimodal image-guided surgery of HER2-positive breast cancer using [111In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model

Fig. 4

As an example a SPECT/CT image (supine position) of a mouse bearing a BT474 tumor (a), 48 h after injection of 30 μg [111In]In-DTPA-trastuzumab-IRDye800CW, showing high uptake in the tumor. Fluorescence images before and after resection of the tumor (b, c), with a selected epi-fluorescence scale of 300–1000 counts. *Implanted estradiol pellet

Back to article page